Phio Pharmaceuticals CEO Robert J. Bitterman reports $20,500 common share acquisition
PHIO•Chairman, President and CEO Robert J. Bitterman purchased 25,000 Phio Pharmaceuticals shares at $0.82 each, increasing his direct beneficial ownership to 789,871 shares.
1. Share purchase
Robert J. Bitterman purchased 25,000 shares of Phio Pharmaceuticals common stock at $0.82 per share. His direct beneficial ownership rose to 789,871 shares.
